Brooklyn Investment Group Makes New $101,000 Investment in Waters Co. (NYSE:WAT)

Brooklyn Investment Group bought a new stake in shares of Waters Co. (NYSE:WAT) during the third quarter, HoldingsChannel reports. The firm bought 282 shares of the medical instruments supplier’s stock, valued at approximately $101,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of WAT. Van ECK Associates Corp boosted its stake in Waters by 1.0% during the third quarter. Van ECK Associates Corp now owns 659,539 shares of the medical instruments supplier’s stock worth $219,811,000 after acquiring an additional 6,647 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Waters by 70.7% in the 3rd quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier’s stock worth $236,095,000 after buying an additional 271,804 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Waters by 21.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 448,304 shares of the medical instruments supplier’s stock valued at $130,053,000 after buying an additional 77,951 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its stake in Waters by 34.4% during the third quarter. Robeco Institutional Asset Management B.V. now owns 393,890 shares of the medical instruments supplier’s stock valued at $141,757,000 after buying an additional 100,811 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Waters by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 384,641 shares of the medical instruments supplier’s stock worth $138,428,000 after acquiring an additional 7,865 shares in the last quarter. 94.01% of the stock is owned by hedge funds and other institutional investors.

Waters Trading Down 0.4 %

NYSE:WAT opened at $386.57 on Thursday. The firm has a market capitalization of $22.95 billion, a price-to-earnings ratio of 36.89, a price-to-earnings-growth ratio of 6.92 and a beta of 0.97. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38. The business has a fifty day moving average price of $356.22 and a 200-day moving average price of $332.60. Waters Co. has a one year low of $273.60 and a one year high of $395.44.

Waters (NYSE:WAT) last posted its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. The firm had revenue of $740.30 million for the quarter, compared to analysts’ expectations of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.84 EPS. Sell-side analysts forecast that Waters Co. will post 11.79 EPS for the current year.

Wall Street Analyst Weigh In

WAT has been the subject of several recent analyst reports. Jefferies Financial Group raised Waters from a “hold” rating to a “buy” rating and lifted their price target for the stock from $355.00 to $415.00 in a research report on Tuesday, October 8th. Barclays increased their price target on shares of Waters from $330.00 to $360.00 and gave the company an “underweight” rating in a report on Monday, November 4th. Leerink Partnrs raised Waters from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 1st. Leerink Partners raised Waters from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $325.00 to $375.00 in a report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $365.85.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.